The Serum Institute of India (SII) said on Wednesday that the drugmaker will follow instructions from the central drug regulator on suspending the Oxford-AstraZeneca COVID-19 vaccine trial in India. The Controller General of Drugs of India (DCGI) issued a notice of demonstrative cause to the Serum Institute of India on …
Read More »Oxford COVID-19 vaccine trial suspended in India? ‘It will comply with DCGI’s instructions,’ says Serum Institute
